Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
about
Conservative treatments in gynaecological cancer for fertility preservationConservative treatments in gynaecological cancer for fertility preservationFertility sparing surgery in gynecologic cancerNew concepts for an old problem: the diagnosis of endometrial hyperplasiaProgestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancerARID1A Is Essential for Endometrial Function during Early PregnancyAssessing endometrial hyperplasia and carcinoma treated with progestin therapy.Loss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus.Controversies in the management of endometrial cancer.Controversies in the management of endometrial carcinoma.Preserving fertility in young patients with endometrial cancer: current perspectives.Role of progesterone in endometrial cancerProgestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapySuccessful treatment of early endometrial carcinoma by local delivery of levonorgestrel: a case report.Steroid hormone intervenes in the endometrial tumorigenesis of pten ablation.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature.Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature.Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.Breast cancer in the setting of fertility-sparing treatment for endometrial cancerInfluence of AKT on progesterone action in endometrial diseases.Progestin intrauterine device in an adolescent with grade 2 endometrial cancer.Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls.Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young womenIdentifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping.Fertility-sparing therapy for young women with endometrial cancer.Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report.Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devicesMeasurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinomaProgestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.A novel saline infusion sonohysterography-based strain imaging approach for evaluation of uterine abnormalities in vivo: preliminary resultsCritical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.Fertility sparing treatment in young patients with early endometrial adenocarcinoma: case series.Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells
P2860
Q24194723-E42AF376-A90B-458E-AB53-6EB00436BFD0Q24236751-01AEDA38-FFB7-43A7-9C24-1796C38CB498Q26827531-67204971-BDEC-49D3-B126-2C8C8E6E7529Q28071864-9428FC71-FB1F-46B9-9203-9B3CB46DDC1FQ28083257-E01F37B6-E565-4AC2-AF0F-CA0B2D8EC6EFQ30370823-0339F599-E3DB-45DA-857F-D9BD88D1A4EBQ30456152-D55DC86F-4872-498A-A908-6B9A6698582DQ33826091-D97CFF54-66BC-4591-B96F-49091070330FQ33960860-82BB991A-C9FE-4F8D-B612-5AEFA97E8CBEQ33960894-360F4563-86A1-4444-84BF-986359FAE3B0Q34005400-436521D5-132B-4D7C-A9E5-D7667E3D1D31Q34095034-E833F35C-0E20-4925-9D9B-8C64EACB75DEQ34140562-839C6955-8327-40BF-BEDB-6025C6505B8EQ34173018-E7F2803E-34E1-46ED-86BF-97A26FD9F45BQ34235834-7EE759BF-ECD9-4D4F-AD1C-D73446821131Q34305296-6A928051-062D-4041-A879-6D196BF0672EQ34321877-4F288B43-3D86-4110-ACF5-BEF7BFF90540Q34353091-DFE7AF6C-7434-4DED-96B1-08509D430823Q34388048-AB407A52-F166-484C-86DC-30E154F5C801Q35106159-1D4B5573-60E7-4DC0-9818-7F06B3BA3AF6Q35551056-EAC02173-A933-4C69-BC50-9220C696ECD4Q35614080-32014FB7-2656-4338-904E-42ED970A3A3FQ35617565-25B64986-A9E4-4355-A32B-BC175D927033Q35697202-8D63BBEE-6BCD-44DC-B698-2D23166871EAQ35886066-BE923AEF-6085-43A3-A6B0-165E89A1F51AQ35945498-4731817A-5A9F-437E-A44A-D48D110DEE86Q36183292-1DFBCAA2-56EC-4954-BF50-4EECD4604CEDQ36263947-1A4D13B2-5C63-470C-B51A-D9B4CA14CE1AQ36352064-F63D0213-A447-4545-A351-840885423826Q36466930-78F15081-24D6-46F5-BA99-54A83C366B4BQ36547575-95C96A4D-641F-4B09-96B0-4D6A9ED8CAF7Q36658754-97CDC4EF-1E1F-4E34-8517-3A59A498EFB7Q36669005-7E9DFC2B-E7F3-482E-910C-689C879A8B05Q36741896-0925765E-5959-430F-AB5F-A4CF4649C700Q36825389-BCA7849A-83C1-444A-9513-D0CF1D669AF4Q36860495-69AEADBA-9765-44DC-AC95-118E6D6780C5Q37100117-457D00CD-518B-42BD-BF83-0A382147E2EFQ37199883-F0EEBEEA-8805-4680-9D27-A7222104D267Q37257915-452D92E4-E4D9-473D-9435-5AB25B581FA8Q37273132-A050E533-0906-42B3-8CA1-6788C7422E17
P2860
Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hormonal therapy for the manag ...... arcinoma: a literature review.
@ast
Hormonal therapy for the manag ...... arcinoma: a literature review.
@en
type
label
Hormonal therapy for the manag ...... arcinoma: a literature review.
@ast
Hormonal therapy for the manag ...... arcinoma: a literature review.
@en
prefLabel
Hormonal therapy for the manag ...... arcinoma: a literature review.
@ast
Hormonal therapy for the manag ...... arcinoma: a literature review.
@en
P2093
P1433
P1476
Hormonal therapy for the manag ...... carcinoma: a literature review
@en
P2093
Charles Levenback
Charlotte C Sun
Pedro T Ramirez
P304
P356
10.1016/J.YGYNO.2004.06.045
P407
P577
2004-10-01T00:00:00Z